Search Results - "Sakiyama, Tsutomu"

Risk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection by Kidera, Yasuhiro, Kawakami, Hisato, Sakiyama, Tsutomu, Okamoto, Kunio, Tanaka, Kaoru, Takeda, Masayuki, Kaneda, Hiroyasu, Nishina, Shin-ichi, Tsurutani, Junji, Fujiwara, Kimiko, Nomura, Morihiro, Yamazoe, Yuzuru, Chiba, Yasutaka, Nishida, Shozo, Tamura, Takao, Nakagawa, Kazuhiko

“…Nephrotoxicity remains a problem for patients who receive cisplatin chemotherapy. We retrospectively evaluated potential risk factors for cisplatin-induced…”
Get full text

Phase I trial of 5-FU, docetaxel, and nedaplatin (UDON) combination therapy for recurrent or metastatic esophageal cancer by Ueda, Shinya, Kawakami, Hisato, Nishina, Shinichi, Sakiyama, Tsutomu, Nonagase, Yoshikane, Okabe, Takafumi, Tamura, Takao, Nakagawa, Kazuhiko

“…Purpose The aims of this dose-escalating phase I study were to determine the maximum tolerable dose (MTD) and recommended dose (RD) of 5-fluorouracil (5-FU),…”
Get full text

Phase I Trial of 5-FU, Docetaxel and Nedaplatin Combination Therapy for Metastatic Esophageal Cancer by Shinichi, Nishina, Shinya, Ueda, Yoshikane, Nonagase, Takafumi, Okabe, Hisato, Kawakami, Tsutomu, Sakiyama, Takao, Tamura, Kazuhiko, Nakagawa

Get full text

Disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation as the first symptom of recurrent rectal cancer successfully treated with chemotherapy: A case report and review of the literature by Takeyama, Hiroshi, Sakiyama, Tsutomu, Wakasa, Tomoko, Kitani, Kotaro, Inoue, Keisuke, Kato, Hiroaki, Ueda, Shinya, Tsujie, Masanori, Fujiwara, Yoshinori, Yukawa, Masao, Ohta, Yoshio, Inoue, Masatoshi

“…Disseminated carcinomatosis of the bone marrow (DCBM) is a condition in which bone marrow (BM) metastases diffusely invade the BM, and is frequently…”
Get full text

Phase I Trial of Eribulin/S-1 Combination Therapy for Advanced/Recurrent Breast Cancer by Iwasa, Tsutomu, Sakiyama, Tsutomu, Tsurutani, Junji, Tanaka, Kaoru, Yoshida, Takeshi, Nonagase, Yoshikane, Fujisaka, Yasuhito, Kurata, Takayasu, Komoike, Yoshifumi, Nakagawa, Kazuhiko

Get full text

MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy by Murakami, Taichi, Nagai, Kojiro, Matsuura, Motokazu, Kondo, Naoki, Kishi, Seiji, Araoka, Toshikazu, Kishi, Fumi, Sakiyama, Tsutomu, Mima, Akira, Bando, Yoshimi, Abe, Hideharu, Doi, Toshio

“…Anti-glomerular basement membrane (GBM) antibody disease is clinically manifested as rapidly progressive glomerulonephritis (RPGN) with crescentic changes. The…”
Get more information